-+ 0.00%
-+ 0.00%
-+ 0.00%

WORK Medical Technology Inks Agreement With Shanghai Novabioplus Biotechnology Over Joint Development Of Intelligent Medical Models

Benzinga·05/11/2026 13:18:49
Listen to the news

WORK Medical Technology Group LTD (NASDAQ:WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China, through its subsidiaries in China, today announced that it has entered into a strategic cooperation agreement (the "Agreement") with Shanghai Novabioplus Biotechnology Co., Ltd. ("Novabioplus"), a provider of biological reagent products and solutions on April 13, 2026.

The two parties aim to jointly develop a "Data-Model-Application" trinity of next-generation intelligent medical models. The long-term initiative aims to integrate WORK Medical's digital transformation of AI-driven healthcare with Novabioplus' extensive protein data resources and application scenarios, unlocking the latent value of biological data assets.